Showing results (4981-4990 of 5,051) with videos related to
Sort By:
Pageof 506
Headache|May 6, 2024
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I studyDawn C Buse, Fumihiko Sakai, Manjit Matharu, et al.Headache|October 5, 2023
Plasma calcitonin gene-related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussionAnn I Scher, James S McGinley, Lyndsey R VanDam, et al.Headache|September 20, 2024
Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose studyJames Rucker, Matt Butler, Sadie Hambleton, et al.Headache|September 30, 2024
Efficacy of galcanezumab in proline-rich transmembrane protein 2 (PRRT2)-associated familial hemiplegic migraine: A case seriesCostanza Sottani, Giulia Di Lazzaro, Paolo Calabresi, et al.Headache|September 13, 2024
Comparison of clinical pharmacist practitioners' headache care roles across clinical contexts within the Veterans Health Administration: Optimizing pharmacist integrationRoberta E Goldman, Teresa M Damush, Alexander B Guirguis, et al.Headache|October 14, 2024
Characteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort studyElizabeth K Seng, Mark J Burish, Brenda T Fenton, et al.Headache|October 14, 2024
Feasibility, acceptability, and fidelity of remote-delivered abbreviated mindfulness-based cognitive therapy interventions for patients with migraine and depressive symptomsElizabeth K Seng, Jacob Hill, Annie Kate Reeder, et al.Headache|September 30, 2024
A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT studyJeffrey D Sharon, Roseanne Krauter, Ricky Chae, et al.Headache|September 26, 2024
Ubrogepant users' real-world experience: Patients on ubrogepant, characteristics and outcomes (UNIVERSE) studyAnand R Shewale, Weijie Poh, Michael L Reed, et al.Headache|May 26, 2023
Decision-making impairment under ambiguity but not under risk may underlie medication overuse in patients with chronic migraineChi Ieong Lau, Wei-Hung Chen, Han-Cheng Wang, et al.Pageof 506